UA88772C2 - Соединения для лечения расстройств метаболизма - Google Patents

Соединения для лечения расстройств метаболизма

Info

Publication number: UA88772C2
Authority: UA; Ukraine
Prior art keywords: carbon atoms; ris; alkyl; hydrogen; ring
Prior art date: 2003-08-20

Application number

UAA200602860A

Other languages

English (en)

Ukrainian (uk)

Inventor

Шалини ШАРМА

Борштель Рид У. фон

Кирвин Л. ХОДЖ

Original Assignee

Уэллстат Терепьютикс Корпорейшн

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-08-20

Filing date

2004-08-16

Publication date

2009-11-25

2004-08-16 Application filed by Уэллстат Терепьютикс Корпорейшн filed Critical Уэллстат Терепьютикс Корпорейшн

2009-11-25 Publication of UA88772C2 publication Critical patent/UA88772C2/ru

Links

150000001875 compounds Chemical class 0.000 title abstract 3
208000030159 metabolic disease Diseases 0.000 title abstract 2
125000004432 carbon atom Chemical group C* 0.000 abstract 8
229910052739 hydrogen Inorganic materials 0.000 abstract 6
239000001257 hydrogen Substances 0.000 abstract 6
125000000217 alkyl group Chemical group 0.000 abstract 5
150000002431 hydrogen Chemical class 0.000 abstract 3
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 3
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
125000003545 alkoxy group Chemical group 0.000 abstract 2
125000000753 cycloalkyl group Chemical group 0.000 abstract 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 2
125000005843 halogen group Chemical group 0.000 abstract 2
125000001072 heteroaryl group Chemical group 0.000 abstract 2
206010003210 Arteriosclerosis Diseases 0.000 abstract 1
201000001320 Atherosclerosis Diseases 0.000 abstract 1
206010006895 Cachexia Diseases 0.000 abstract 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
101150065749 Churc1 gene Proteins 0.000 abstract 1
208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
208000031773 Insulin resistance syndrome Diseases 0.000 abstract 1
208000008589 Obesity Diseases 0.000 abstract 1
102100038239 Protein Churchill Human genes 0.000 abstract 1
125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
229910052799 carbon Inorganic materials 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
206010012601 diabetes mellitus Diseases 0.000 abstract 1
208000010706 fatty liver disease Diseases 0.000 abstract 1
125000005842 heteroatom Chemical group 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
235000020824 obesity Nutrition 0.000 abstract 1
-1 perfluoromethoxy Chemical group 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Ophthalmology & Optometry (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Neurosurgery (AREA)
Child & Adolescent Psychology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Vascular Medicine (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

UAA200602860A 2003-08-20 2004-08-16 Соединения для лечения расстройств метаболизма UA88772C2 (ru)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US49653303P	2003-08-20	2003-08-20

Publications (1)

Publication Number	Publication Date
UA88772C2 true UA88772C2 (ru)	2009-11-25

Family

ID=34216015

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UAA200602860A UA88772C2 (ru)	2003-08-20	2004-08-16	Соединения для лечения расстройств метаболизма

Country Status (18)

Country	Link
US (1)	US7906675B2 (ru)
EP (1)	EP1656127B1 (ru)
JP (1)	JP4703563B2 (ru)
KR (1)	KR101069276B1 (ru)
CN (2)	CN101948416A (ru)
AT (1)	ATE502631T1 (ru)
AU (1)	AU2004266673B2 (ru)
BR (1)	BRPI0413758A (ru)
CA (1)	CA2533890A1 (ru)
DE (1)	DE602004031954D1 (ru)
IL (1)	IL173377A (ru)
MX (1)	MXPA06001963A (ru)
NO (1)	NO20060502L (ru)
NZ (1)	NZ545268A (ru)
RU (1)	RU2349584C2 (ru)
UA (1)	UA88772C2 (ru)
WO (1)	WO2005018628A1 (ru)
ZA (1)	ZA200600577B (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2530235T3 (es) *	2003-02-13	2015-02-27	Wellstat Therapeutics Corporation	Compuestos para el tratamiento de trastornos metabólicos
ES2353601T3 (es) *	2003-04-15	2011-03-03	Wellstat Therapeutics Corporation	Compuestos para el tratamiento de trastornos metabólicos.
CA2522738C (en) *	2003-04-30	2011-11-08	Wellstat Therapeutics Corporation	Compounds for the treatment of metabolic disorders
WO2006127133A2 (en) *	2005-04-01	2006-11-30	Wellstat Therapeutics Corporation	Compounds for the treatment of metabolic disorders
UA95613C2 (ru) *	2005-11-09	2011-08-25	Уеллстат Терепьютикс Корпорейшн	Соединения для лечения расстройсв метаболизма
US7820721B2 (en) *	2006-01-25	2010-10-26	Wellstat Therapeutics Corporation	Compounds for the treatment of metabolic disorders
EP1976510A4 (en) *	2006-01-25	2010-06-09	Wellstat Therapeutics Corp	COMPOUNDS FOR THE TREATMENT OF METABOLISM DISORDER
AU2007208127A1 (en) *	2006-01-25	2007-08-02	Wellstat Therapeutics Corporation	Compounds for the treatment of metabolic disorders
JP2009525982A (ja) *	2006-02-02	2009-07-16	ウェルスタットセラピューティクスコーポレイション	代謝障害の治療のための化合物
EP1983972A4 (en) *	2006-02-13	2012-01-25	Wellstat Therapeutics Corp	COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
KR20080098615A (ko) *	2006-02-28	2008-11-11	웰스태트 테러퓨틱스 코포레이션	물질대사 장애의 치료용 화합물
WO2007117791A2 (en) *	2006-03-31	2007-10-18	Wellstat Therapeutics Corporation	Combination treatment of metabolic disorders
CA2651598A1 (en) *	2006-05-18	2007-11-29	Wellstat Therapeutics Corporation	Compounds for the treatment of metabolic disorders
US20100234464A1 (en) *	2006-06-09	2010-09-16	Wellstat Therapeutics Corporation	Compounds for the treatment of metabolic disorders
WO2009091732A1 (en) *	2008-01-15	2009-07-23	Wellstat Therapeutics Corporation	Compounds for the treatment of metabolic disorders
CN109096350B (zh) *	2017-09-21	2020-07-28	暨南大学	辣木籽中新的硫醚类化合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE667498A (ru)	1964-07-28	1965-11-16
CN1315473C (zh) *	1997-03-17	2007-05-16	英国技术集团国际有限公司	治疗组合物
RU2341513C2 (ru) *	2001-06-12	2008-12-20	Веллстат Терапьютикс Корпорейшн	Соединения для лечения метаболических заболеваний
CA2502297C (en) *	2002-11-01	2011-12-13	Wellstat Therapeutics Corporation	Compounds for the treatment of metabolic disorders
ES2530235T3 (es) *	2003-02-13	2015-02-27	Wellstat Therapeutics Corporation	Compuestos para el tratamiento de trastornos metabólicos
ES2353601T3 (es) *	2003-04-15	2011-03-03	Wellstat Therapeutics Corporation	Compuestos para el tratamiento de trastornos metabólicos.
CN1777576A (zh) *	2003-04-22	2006-05-24	维尔斯达医疗公司	用于治疗代谢紊乱的化合物
CA2522738C (en) *	2003-04-30	2011-11-08	Wellstat Therapeutics Corporation	Compounds for the treatment of metabolic disorders

2004
- 2004-08-16 MX MXPA06001963A patent/MXPA06001963A/es active IP Right Grant
- 2004-08-16 CN CN2010102937097A patent/CN101948416A/zh active Pending
- 2004-08-16 US US10/566,302 patent/US7906675B2/en active Active
- 2004-08-16 CA CA002533890A patent/CA2533890A1/en not_active Abandoned
- 2004-08-16 UA UAA200602860A patent/UA88772C2/ru unknown
- 2004-08-16 NZ NZ545268A patent/NZ545268A/en unknown
- 2004-08-16 JP JP2006523964A patent/JP4703563B2/ja not_active Expired - Fee Related
- 2004-08-16 EP EP04781277A patent/EP1656127B1/en not_active Expired - Lifetime
- 2004-08-16 KR KR1020067003221A patent/KR101069276B1/ko not_active Expired - Fee Related
- 2004-08-16 RU RU2006108572/04A patent/RU2349584C2/ru not_active IP Right Cessation
- 2004-08-16 DE DE602004031954T patent/DE602004031954D1/de not_active Expired - Lifetime
- 2004-08-16 AT AT04781277T patent/ATE502631T1/de not_active IP Right Cessation
- 2004-08-16 CN CNA2004800235529A patent/CN1835743A/zh active Pending
- 2004-08-16 WO PCT/US2004/026561 patent/WO2005018628A1/en not_active Ceased
- 2004-08-16 BR BRPI0413758-2A patent/BRPI0413758A/pt not_active IP Right Cessation
- 2004-08-16 AU AU2004266673A patent/AU2004266673B2/en not_active Ceased
2006
- 2006-01-23 ZA ZA200600577A patent/ZA200600577B/en unknown
- 2006-01-26 IL IL173377A patent/IL173377A/en not_active IP Right Cessation
- 2006-01-31 NO NO20060502A patent/NO20060502L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NZ545268A (en)	2009-05-31
JP2007502824A (ja)	2007-02-15
US20070282003A1 (en)	2007-12-06
CA2533890A1 (en)	2005-03-03
KR20060066730A (ko)	2006-06-16
CN101948416A (zh)	2011-01-19
AU2004266673B2 (en)	2010-08-05
IL173377A (en)	2012-12-31
BRPI0413758A (pt)	2006-10-31
RU2349584C2 (ru)	2009-03-20
ATE502631T1 (de)	2011-04-15
MXPA06001963A (es)	2006-05-31
EP1656127B1 (en)	2011-03-23
HK1087040A1 (en)	2006-10-06
CN1835743A (zh)	2006-09-20
US7906675B2 (en)	2011-03-15
EP1656127A4 (en)	2009-04-29
DE602004031954D1 (de)	2011-05-05
WO2005018628A1 (en)	2005-03-03
RU2006108572A (ru)	2006-07-27
JP4703563B2 (ja)	2011-06-15
ZA200600577B (en)	2007-01-31
NO20060502L (no)	2006-05-03
IL173377A0 (en)	2006-06-11
AU2004266673A1 (en)	2005-03-03
EP1656127A1 (en)	2006-05-17
KR101069276B1 (ko)	2011-10-04

Publication	Publication Date	Title
CY1111310T1 (el)	2015-08-05	Ενωσεις για την αγωγη μεταβολικων διαταραχων
WO2004073611A3 (en)	2004-11-25	Compounds for the treatment of metabolic disorders
UA95613C2 (ru)	2011-08-25	Соединения для лечения расстройсв метаболизма
IL193321A0 (en)	2009-08-03	Compounds for the treatment of metabolic disorders
WO2007095462A3 (en)	2008-05-02	Compounds for the treatment of metabolic disorders
MXPA05011592A (es)	2005-12-15	Compuestos para el tratamiento de trastornos metabolicos.
WO2007087505A3 (en)	2007-12-13	Compounds for the treatment of metabolic disorders
WO2004093806A3 (en)	2005-04-07	Compounds for the treatment of metabolic disorders
WO2005105732A8 (en)	2007-04-19	Substituted methyl aryl or heteroaryl amide compounds
NO20003399L (no)	2000-08-02	<Alfa>-amionoamidderivater som er nyttige som smertestillende midler
CA2565660A1 (en)	2005-11-10	Ortho substituted aryl or heteroaryl amide compounds
WO2007087506A3 (en)	2007-11-22	Compounds for the treatment of metabolic disorders
WO2007117791A3 (en)	2008-08-21	Combination treatment of metabolic disorders
BRPI0413758A (pt)	2006-10-31	compostos para o tratamento de transtornos metabólicos
NZ601408A (en)	2013-12-20	Novel 3-hydroxy-5-arylisothiazole derivative
WO2007087504A3 (en)	2007-11-15	Compounds for the treatment of metabolic disorders
EP1868595A4 (en)	2010-06-09	COMPOUNDS FOR THE TREATMENT OF METABOLISM DISORDER
WO2007092729A3 (en)	2007-12-13	Compounds for the treatment of metabolic disorders